Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
According to Novo Nordisk's latest financial reports the company's total liabilities are โน4.836 Trillion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.